Evidence map›Paper›PMID 35797848›Full record

ArticleEnzyme and microbial technology2022

Applying molecular and phenotypic screening assays to identify efficient quorum quenching lactonases.

Raphaël Billot, Laure Plener, Damien Grizard, Mikael H Elias, Éric Chabrière, David Daudé

Open access · greenAbstract read
In one paragraph

Article in Enzyme and microbial technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Engineering quorum quenching acylases with improved kinetic and biochemical properties.Protein science : a publication of the Protein Society · 2024
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Raphaël BillotGene&GreenTK, 19-21 Boulevard Jean Moulin, 13005 Marseille, France; Aix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.
Laure PlenerGene&GreenTK, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.
Damien GrizardGene&GreenTK, 19-21 Boulevard Jean Moulin, 13005 Marseille, France; Proxis Développement, Levallois-Perret, France.
Mikael H EliasDepartment of Biochemistry, Molecular Biology and Biophysics - BioTechnology Institute, University of Minnesota, St. Paul, MN, United States.
Éric ChabrièreAix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.
David DaudéGene&GreenTK, 19-21 Boulevard Jean Moulin, 13005 Marseille, France. Electronic address: david.daude@gene-greentk.com.
Gene and GreenTK (France) · FRInstitut de Recherche pour le Développement · FRUniversity of Minnesota · US

Funding

Unravelling the Importance of Bacterial Signaling using Specific Interference StrategiesR35GM133487 · NIGMS · UNIVERSITY OF MINNESOTA · PI Mikael H Elias · 2019 to 2026
$2.7M
NIGMS NIH HHS R35 GM133487
6 · The paper itself

Abstract

Quorum sensing (QS) is a molecular communication system used by microorganisms to adopt behaviors in a cell density-dependent manner. Lactonase enzymes, able to hydrolyze the signal molecules acyl-homoserine lactones (AHL) can counteract QS-mediated virulence in Gram-negative bacteria. Optimizing lactonases activity or specificity for AHL through enzyme engineering approaches is thus highly attractive to increase protective effect. However, only a limited number of screening methods have been developed to handle and evaluate AHL-degrading enzyme libraries. Here, a series of screening procedures were developed to identify improved lactonases using two previously reported enzymes as benchmarks, namely SsoPox and GcL. Specifically, molecular screenings using six different AHL and based on two reporter strains; i.e., Chromobacterium violaceum CV026 and Pseudomonas putida KS35, are reported. In addition, three phenotype-based screenings aiming to evaluate the ability of enzymes to quench a particular QS-related behavior are reported, using C. violaceum, Pseudomonas aeruginosa and Vibrio harveyi as pathogenic type strains. These assays were used to screen a small-sized library and allowed for the identification of various improved variants. To confirm that these variants were real "hits", four of them were produced and purified. Their kinetic parameters against AHL substrates were found to be increased by 2-44.5 -fold as compared to the starting enzyme. Moreover, their increased activity was confirmed by measuring their ability to quench QS in different bacterial systems. These new assays will facilitate the screening of enzyme libraries and will pave the way for the development of proficient engineered QS-disrupting enzymes.

Indexed as

Acyl-ButyrolactonesQuorum SensingPhenotypePseudomonas aeruginosaVirulenceAcyl-ButyrolactonesAcyl homoserine lactonesEnzyme, engineeringEnzyme screeningLactonaseQuorum quenchingQuorum sensing

Identifiers

PMID35797848
PMCPMC10310055
OpenAlexW4283740022

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.